CIK: 0001534261
Total reported value
$1.3B
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | SG7 | Sage Therapeutics INC | Stock-Other | 10.69% | — | -1.73% | |
| 2 | ✓ | Foundation Medicine INC | Stock-Other | 9.13% | — | -12.09% | |
| 3 | ✓ | Loxo Oncology INC | Stock-Other | 8.94% | — | — | |
| 4 | AGIO | Agios Pharmaceuticals INC | Stock-Other | 8.18% | — | -1.25% | |
| 5 | 2655787D | Blueprint Medicines CORP | Stock-Other | 6.95% | — | +20.45% | |
| 6 | EVH | Evolent Health INC - A | Stock-Other | 6.84% | — | -6.31% | |
| 7 | EPZMEUR | Epizyme INC | Stock-Other | 4.91% | — | +76.36% | |
| 8 | ONCEEUR | Spark Therapeutics INC | Stock-Other | 4.25% | — | +5.06% | |
| 9 | VYGR | Voyager Therapeutics INC | Stock-Other | 3.91% | — | +29.87% | |
| 10 | GNMK | Genmark Diagnostics INC | Stock-Other | 3.03% | — | -21.57% | |
| 11 | BOLDEUR | Audentes Therapeutics INC | Stock-Other | 2.61% | — | — | |
| 12 | SGMOQ | Sangamo Therapeutics INC | Stock-Other | 2.61% | — | — | |
| 13 | MDRX | Veradigm INC | Stock-Other | 2.32% | — | +10.71% | |
| 14 | GBTUSD | Global Blood Therapeutics In | Stock-Other | 2.21% | — | -66.61% | |
| 15 | PACB | Pacific Biosciences Of Calif | Stock-Other | 2.13% | -0.42% | — | |
| 16 | MYOKEUR | Myokardia INC | Stock-Other | 2.06% | — | — | |
| 17 | KRG | Kite Realty Group Trust | Stock-Real Estate | 1.97% | — | -54.79% | |
| 18 | CDXS | Codexis INC | Stock-Other | 1.91% | — | — | |
| 19 | ✓ | Amyris INC | Stock-Other | 1.88% | — | +75.18% | |
| 20 | CTMX | Cytomx Therapeutics INC | Stock-Other | 1.81% | — | +39.22% | |
| 21 | EDIT | Editas Medicine INC | Stock-Other | 1.76% | — | +105.13% | |
| 22 | SYRSEUR | Syros Pharmaceuticals INC | Stock-Other | 1.71% | — | — | |
| 23 | JNCEEUR | Jounce Therapeutics INC | Stock-Other | 1.69% | — | — | |
| 24 | ALNY | Alnylam Pharmaceuticals INC | Stock-Healthcare | 1.66% | +0.03% | -35.29% | |
| 25 | T8S | Tesaro INC | Stock-Other | 1.59% | — | — | |
| 26 | ✓ | Stock-Other | 1.37% | — | -69.09% | ||
| 27 | CLVSEUR | Clovis Oncology INC | Stock-Other | 0.86% | — | — | |
| 28 | ADVMCHF | Adverum Biotechnologies INC | Stock-Other | 0.67% | — | — | |
| 29 | ✓ | Curis INC | Stock-Other | 0.38% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | EPZMEUR | Epizyme INC | +2.2% | +76.36% | Add |
| 2 | 2655787D | Blueprint Medicines CORP | +1.3% | +20.45% | Add |
| 3 | ✓ | Foundation Medicine INC | +1.2% | -12.09% | Trim |
| 4 | EDIT | Editas Medicine INC | +0.9% | +105.13% | Add |
| 5 | CTMX | Cytomx Therapeutics INC | +0.7% | +39.22% | Add |
| 6 | EVH | Evolent Health INC - A | +0.1% | -6.31% | Trim |
| 7 | MDRX | Veradigm INC | 0% | +10.71% | Add |
| 8 | AGIO | Agios Pharmaceuticals INC | -0.1% | -1.25% | Trim |
| 9 | SYRSEUR | Syros Pharmaceuticals INC | -0.1% | — | Unchanged |
| 10 | VYGR | Voyager Therapeutics INC | -0.1% | +29.87% | Add |
| 11 | ✓ | Amyris INC | -0.2% | +75.18% | Add |
| 12 | SG7 | Sage Therapeutics INC | -0.3% | -1.73% | Trim |
| 13 | ✓ | Loxo Oncology INC | -0.6% | — | Unchanged |
| 14 | MYOKEUR | Myokardia INC | -0.8% | — | Unchanged |
| 15 | ALNY | Alnylam Pharmaceuticals INC | -1% | -35.29% | Trim |
| 16 | ONCEEUR | Spark Therapeutics INC | -1.1% | +5.06% | Add |
| 17 | GBTUSD | Global Blood Therapeutics In | -1.4% | -66.61% | Trim |
| 18 | KRG | Kite Realty Group Trust | -1.5% | -54.79% | Trim |
| 19 | GNMK | Genmark Diagnostics INC | -2.1% | -21.57% | Trim |
| 20 | ✓ | -2.8% | -69.09% | Trim | |
| 21 | BOLDEUR | Audentes Therapeutics INC | — | NEW | New buy |
| 22 | SGMOQ | Sangamo Therapeutics INC | — | NEW | New buy |
| 23 | PACB | Pacific Biosciences Of Calif | — | NEW | New buy |
| 24 | CDXS | Codexis INC | — | NEW | New buy |
| 25 | ILMN | Illumina INC | — | EXIT | Sold out |
| 26 | CERNCHF | Cerner CORP | — | EXIT | Sold out |
| 27 | JNCEEUR | Jounce Therapeutics INC | — | NEW | New buy |
| 28 | T8S | Tesaro INC | — | NEW | New buy |
| 29 | GNMXEUR | Aevi Genomic Medicine INC | — | EXIT | Sold out |
| 30 | CLVSEUR | Clovis Oncology INC | — | NEW | New buy |
| 31 | XLRN | Acceleron Pharma INC | — | EXIT | Sold out |
| 32 | ADVMCHF | Adverum Biotechnologies INC | — | NEW | New buy |
| 33 | GILD | Gilead Sciences INC | — | EXIT | Sold out |
| 34 | ✓ | Curis INC | — | NEW | New buy |